loading
前日終値:
$1.185
開ける:
$1.2295
24時間の取引高:
108.90K
Relative Volume:
0.89
時価総額:
$17.61M
収益:
$321.50K
当期純損益:
$-7.24M
株価収益率:
-0.6686
EPS:
-1.7498
ネットキャッシュフロー:
$-5.72M
1週間 パフォーマンス:
-7.87%
1か月 パフォーマンス:
-16.43%
6か月 パフォーマンス:
-56.18%
1年 パフォーマンス:
-17.02%
1日の値動き範囲:
Value
$1.03
$1.2295
1週間の範囲:
Value
$1.03
$1.33
52週間の値動き範囲:
Value
$1.03
$3.62

Bioaffinity Technologies Inc Stock (BIAF) Company Profile

Name
名前
Bioaffinity Technologies Inc
Name
セクター
Healthcare (1200)
Name
電話
210-698-5334
Name
住所
22211 WEST INTERSTATE-10, SAN ANTONIO
Name
職員
75
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
BIAF's Discussions on Twitter

BIAF を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
BIAF
Bioaffinity Technologies Inc
1.17 17.61M 321.50K -7.24M -5.72M -1.7498
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

Bioaffinity Technologies Inc (BIAF) 最新ニュース

pulisher
Nov 21, 2024

bioAffinity Technologies stock hits 52-week low at $1.21 By Investing.com - Investing.com UK

Nov 21, 2024
pulisher
Nov 20, 2024

BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024
pulisher
Nov 15, 2024

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Zenopa

Nov 15, 2024
pulisher
Nov 15, 2024

bioAffinity Technologies Reports Strong Q3 Growth - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

bioAffinity Technologies stock hits 52-week low at $1.24 By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

bioAffinity Technologies Inc (BIAF) Quarterly 10-Q Report - Quartz

Nov 14, 2024
pulisher
Nov 05, 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Zenopa

Nov 05, 2024
pulisher
Nov 05, 2024

bioAffinity appoints new Chief Science Officer By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

bioAffinity appoints new Chief Science Officer - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

bioAffinity Technologies Appoints William Bauta, Ph.D., as Chief Science Officer - citybiz

Nov 04, 2024
pulisher
Nov 04, 2024

BioAffinity Technologies appoints William Bauta, Ph.D. Chief Science Officer - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development | BIAF Stock News - StockTitan

Nov 04, 2024
pulisher
Oct 31, 2024

J. Michael Edwards Named CFO at bioAffinity Technologies - MPO-mag

Oct 31, 2024
pulisher
Oct 31, 2024

SA company sets the stage for Asian expansion - The Business Journals

Oct 31, 2024
pulisher
Oct 31, 2024

bioAffinity’s CyPath Lung Test Now Available to U.S. Veterans - MPO-mag

Oct 31, 2024
pulisher
Oct 31, 2024

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Zenopa

Oct 31, 2024
pulisher
Oct 30, 2024

bioAffinity secures Japanese patent for lung health test By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

BIAFbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

bioAffinity secures Japanese patent for lung health test - Investing.com

Oct 30, 2024
pulisher
Oct 21, 2024

bioAffinity Technologies Closes of $2.6 Million Registered Direct Offering & Concurrent Private Placement - citybiz

Oct 21, 2024
pulisher
Oct 21, 2024

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 21, 2024
pulisher
Oct 21, 2024

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 21, 2024
pulisher
Oct 21, 2024

SEC Form 424B5 filed by bioAffinity Technologies Inc. - Quantisnow

Oct 21, 2024
pulisher
Oct 18, 2024

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 18, 2024
pulisher
Oct 18, 2024

bioAffinity Technologies Prices of $2.66 Million Registered Direct Offering & Concurrent Private Placement - citybiz

Oct 18, 2024
pulisher
Oct 18, 2024

BioAffinity Technologies Down 25% on Stock Sale, Warrant Private Placement - MarketWatch

Oct 18, 2024
pulisher
Oct 18, 2024

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 18, 2024
pulisher
Oct 16, 2024

bioAffinity VP contributes to new cytometry guidelines - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

bioAffinity VP contributes to new cytometry guidelines By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines - StockTitan

Oct 16, 2024
pulisher
Oct 12, 2024

Lung cancer test speeds growth of San Antonio's bioAffinity - Head Topics

Oct 12, 2024
pulisher
Oct 12, 2024

New lung cancer test uses phlegm, machine learning to make early diagnoses - San Antonio Express-News

Oct 12, 2024
pulisher
Oct 11, 2024

SA biomed to expand military market under new CFO - The Business Journals

Oct 11, 2024
pulisher
Oct 11, 2024

bioAffinity Technologies names J. Michael Edwards as CFO - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

bioAffinity Technologies names J. Michael Edwards as CFO By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer - citybiz

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Welcomes Back CFO for Future Growth - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Appoints J. Michael Edwards as Chief Financial Officer - TechBullion

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans - Mugglehead

Oct 10, 2024
pulisher
Oct 09, 2024

Maxim Group Initiates Coverage of bioAffinity Technologies (BIAF) with Buy Recommendation - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

BioAffinity Technologies : Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test Form 8 K - Marketscreener.com

Oct 09, 2024
pulisher
Oct 09, 2024

bioAffinity Technologies Expands Access to Lung Cancer Test - TipRanks

Oct 09, 2024
pulisher
Oct 09, 2024

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test - StockTitan

Oct 09, 2024
pulisher
Oct 08, 2024

bioAffinity Technologies secures shareholder nod for warrant exercise - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

bioAffinity Technologies secures shareholder nod for warrant exercise By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Sep 24, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Shares Up 9.3% - Defense World

Sep 24, 2024
pulisher
Sep 18, 2024

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - BioSpace

Sep 18, 2024

Bioaffinity Technologies Inc (BIAF) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
大文字化:     |  ボリューム (24 時間):